Testing effectiveness (Phase 2)Looking for participantsNCT07533942What this trial is testingJZP3507 (ONC206) in Recurrent Grade 2 or 3 MeningiomaWho this might be right forMeningioma Jazz Pharmaceuticals 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03604978What this trial is testingNivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III MeningiomaWho this might be right forGrade 2 MeningiomaGrade 3 MeningiomaRecurrent Meningioma National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Looking for participantsNCT07150806What this trial is testingRYZ101 for the Treatment of Progressive or Recurrent Intracranial MeningiomaWho this might be right forRecurrent Meningioma Joshua Palmer 30
Testing effectiveness (Phase 2)Looking for participantsNCT06275919What this trial is testingRegorafenib for Recurrent Meningioma (MIRAGE Trial)Who this might be right forMeningioma, Malignant Istituto Oncologico Veneto IRCCS 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT04659811What this trial is testingStereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent MeningiomaWho this might be right forGrade I Meningioma, AdultGrade II Meningioma, AdultGrade III Meningioma, Adult+1 more Nancy Ann Oberheim Bush, MD 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT02648997What this trial is testingAn Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent MeningiomaWho this might be right forMeningiomas Dana-Farber Cancer Institute 40
Not applicableNot Yet RecruitingNCT07428213What this trial is testingMeasurement of PSMA Expression in Vivo in Recurrent Meningiomas by PET Imaging: a Preliminary Study to a Therapeutic Trial Using Radioligand Therapy (RLT)Who this might be right forMeningioma Hospices Civils de Lyon 40
Not applicableStudy completedNCT00890435What this trial is testingDecision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialWho this might be right forBrain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more Children's Oncology Group 53
Testing effectiveness (Phase 2)Study completedNCT06668987What this trial is testingThe Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent MeningiomaWho this might be right forMeningiomaBoron Neutron Capture Therapy Heron Neutron Medical Corp. 10
Testing effectiveness (Phase 2)Looking for participantsNCT02523014What this trial is testingVismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive MeningiomasWho this might be right forIntracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation Alliance for Clinical Trials in Oncology 124
Not applicableStudy completedNCT02162732What this trial is testingMolecular-Guided Therapy for Childhood CancerWho this might be right forNeuroblastomaMedulloblastomaGlioma+16 more Giselle Sholler 186
Testing effectiveness (Phase 2)Study completedNCT00045734What this trial is testingImatinib Mesylate in Treating Patients With Recurrent MeningiomaWho this might be right forAdult Grade I MeningiomaAdult Grade II MeningiomaAdult Grade III Meningioma+3 more National Cancer Institute (NCI) 23